IS MORE BETTER - DOSE INTENSITY IN NEUROBLASTOMA

被引:18
作者
ANDERSON, JR
COCCIA, PF
机构
关键词
D O I
10.1200/JCO.1991.9.6.902
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:902 / 904
页数:3
相关论文
共 23 条
[11]  
KLESA RJ, 1991, J CLIN ONCOL, V9, P499
[12]   MYELOABLATIVE COMBINATION CHEMOTHERAPY WITHOUT TOTAL-BODY IRRADIATION FOR NEUROBLASTOMA [J].
KUSHNER, BH ;
OREILLY, RJ ;
MANDELL, LR ;
GULATI, SC ;
LAQUAGLIA, M ;
CHEUNG, NKV .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (02) :274-279
[13]  
KUSHNER BH, 1990, CANCER-AM CANCER SOC, V66, P1095, DOI 10.1002/1097-0142(19900915)66:6<1095::AID-CNCR2820660603>3.0.CO
[14]  
2-0
[15]   PROGNOSTIC-SIGNIFICANCE OF ACTUAL DOSE INTENSITY IN DIFFUSE LARGE-CELL LYMPHOMA - RESULTS OF A TREE-STRUCTURED SURVIVAL ANALYSIS [J].
KWAK, LW ;
HALPERN, J ;
OLSHEN, RA ;
HORNING, SJ .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (06) :963-977
[16]   CHEMOTHERAPY FOR ADVANCED AGGRESSIVE LYMPHOMA - MORE IS BETTER ... ISNT IT [J].
LONGO, DL .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (06) :952-955
[17]   EVALUATION OF RESPONSE-TIME DATA INVOLVING TRANSIENT STATES - ILLUSTRATION USING HEART-TRANSPLANT DATA [J].
MANTEL, N ;
BYAR, DP .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1974, 69 (345) :81-86
[18]   THE ROLE OF DOSE INTENSITY IN DETERMINING OUTCOME IN INTERMEDIATE-GRADE NON-HODGKINS-LYMPHOMA [J].
MEYER, RM ;
HRYNIUK, WM ;
GOODYEAR, MDE .
JOURNAL OF CLINICAL ONCOLOGY, 1991, 9 (02) :339-347
[19]   UNFAVORABLE HISTOLOGIES OF NON-HODGKINS-LYMPHOMA TREATED WITH PROMACE-CYTABOM - A GROUPWIDE SOUTHWEST ONCOLOGY GROUP-STUDY [J].
MILLER, TP ;
DAHLBERG, S ;
WEICK, JK ;
FILES, JC ;
EYRE, HJ ;
PENDERGRASS, KB ;
FISHER, RI .
JOURNAL OF CLINICAL ONCOLOGY, 1990, 8 (12) :1951-1958
[20]  
OLEARY M, 1989, P AN M AM SOC CLIN, V8, P307